An update on endotoxaemia Part 2: treatment and the way ahead
- 1 February 1999
- journal article
- Published by Wiley in Equine Veterinary Education
- Vol. 11 (1) , 30-34
- https://doi.org/10.1111/j.2042-3292.1999.tb00915.x
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- The effects of pentoxifylline infusion on plasma 6‐keto‐prostaglandin F 1α and ex vivo endotoxin‐induced tumour necrosis factor activity in horsesJournal of Veterinary Pharmacology and Therapeutics, 1997
- A second large controlled clinical study of E5, a monoclonal antibody to endotoxinCritical Care Medicine, 1995
- Treatment of sepsis by extracorporeal elimination of endotoxin using polymyxin B-inimobilized fiberThe American Journal of Surgery, 1994
- Lipopolysaccharide (LPS) binding protein, truncated at Ile-197, binds LPS but does not transfer LPS to CD14.Journal of Biological Chemistry, 1994
- Administration of a receptor antagonist for platelet-activating factor during equine endotoxaemiaEquine Veterinary Journal, 1993
- A Controlled Clinical Trial of E5 Murine Monoclonal IgM Antibody to Endotoxin in the Treatment of Gram-Negative SepsisJAMA, 1991
- Treatment of Gram-Negative Bacteremia and Septic Shock with HA-1A Human Monoclonal Antibody against EndotoxinNew England Journal of Medicine, 1991
- CD14, a Receptor for Complexes of Lipopolysaccharide (LPS) and LPS Binding ProteinScience, 1990
- Low dose flunixin meglumine: Effects on eicosanoid production and clinical signs induced by experimental endotoxaemia in horsesEquine Veterinary Journal, 1987
- Effects of multiple low doses of flunixin meglumine on repeated endotoxin challenge in the horseProstaglandins, Leukotrienes and Medicine, 1987